eHealthMe - FDA and Social Media, Personalized eHealthMe - FDA and Social Media, Personalized

FDA and Social Media, Personalized


Advanced tools       Explore eHealthMe

From FDA reports: drug interactions between Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets for a Female patient aged 17

This is a personalized study for a 17 year old female patient. The study is created by eHealthMe based on reports of 256 people who take the same drugs and have drug interactionsfrom FDA.

On Jul, 23, 2014: 256 people who reported to have interactions when taking Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets are studied

Trend of Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets's drug interactions, side effects, and effectiveness reports (2090968)

Information of the patient in this study:

Age: 17

Gender: female

Drugs taking:
- Claritin
- Debridat Tablets
- Cefotiam Tablets
- Spasfon Tablets
- Doliprane Tablets

Drug interactions have: Abdominal Pain Nos, Haematuria Present, Nausea, Nephropathy Nos, Proteinuria Present, Renal Disorder Nos, Renal Failure Acute, Vomiting Nos

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 17 (±5):

InteractionNumber of reports
Abdominal Pain Nos2 (28.57%)
Haematuria Present (presence of blood in urine due to trauma)2 (28.57%)
Nausea (feeling of having an urge to vomit)2 (28.57%)
Nephropathy Nos2 (28.57%)
Proteinuria Present2 (28.57%)
Renal Disorder Nos2 (28.57%)
Renal Failure Acute (rapid kidney dysfunction)2 (28.57%)
Vomiting Nos5 (71.43%)

Most common interactions experienced by females aged 17 (±5) in the use of Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets:

InteractionNumber of reports
Vomiting7
Suicide Attempt6
Vomiting Nos5
Multiple Drug Overdose2
Nausea (feeling of having an urge to vomit)2
Breech Presentation2
Renal Disorder Nos2
Proteinuria Present2
Nephropathy Nos2
Renal Failure Acute (rapid kidney dysfunction)2

Most common interactions experienced by females aged 17 (±5) in long term use of Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Abdominal Pain Nos42 (16.41%)
Haematuria Present (presence of blood in urine due to trauma)6 (2.34%)
Nausea (feeling of having an urge to vomit)28 (10.94%)
Nephropathy Nos2 (0.78%)
Proteinuria Present2 (0.78%)
Renal Disorder Nos2 (0.78%)
Renal Failure Acute (rapid kidney dysfunction)18 (7.03%)
Vomiting Nos44 (17.19%)

Most common interactions experienced by people in the use of Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets:

InteractionNumber of reports
Pyrexia (fever)66
Vomiting Nos44
Dizziness (exc Vertigo)44
Abdominal Pain Nos42
Liver Function Tests Nos Abnormal40
Pruritus (severe itching of the skin)39
Nausea (feeling of having an urge to vomit)28
Jaundice Nos26
Drug Interaction Nos23
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)20

Most common interactions experienced by people in long term use of Claritin, Debridat Tablets, Cefotiam Tablets, Spasfon Tablets, Doliprane Tablets:

InteractionNumber of reports
Nocturia (the need to get up in the night to urinate)1
Nephrolithiasis (calculi in the kidneys)1
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell)1
Haemoglobin Decreased1
Haematocrit Decreased1
Injury1
Overdose1
Nausea (feeling of having an urge to vomit)1
Insomnia (sleeplessness)1
Increased Upper Airway Secretion1

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

 

Recent mobile support groups

- Wellbutrin and Rectal Bleeding

- Breast Cancer and Lichen Planus

- Tamiflu for Stress Symptoms

- Metronidazole and Alcohol

- Weight Gain and Atrial Fibrillation

 

Recent user comments

- "I just wanted to know if ABX therapy with these drugs ... " (2 hours ago)

- "I just started taking Atorvastatin 2 months ago and h ... " (2 hours ago)

- "Went for a blood test on Aug. 2013 and the platlet co ... " (4 hours ago)

 

Recent searches

- Renal Cancer Stage Iv
- Platelet Count Decreased
- Garden Rhubarb
- Lisinopril Apotex Inc 10mg
- Bronchitis

Recent updates on eHealthMe:

- Dactylitis in Hypertension (2 seconds ago)

- Juglandis, Procardia Xl drug interactions (3 seconds ago)

- Bile Duct Cancer Recurrent in Influenza (4 seconds ago)

- Duodenal Ulcer in Urticaria Chronic (5 seconds ago)

- Reiter Syndrome in Mirena (6 seconds ago)

   

About - Terms of service - Privacy policy - Press - Advertise - Apps - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.